All about health

Axion BioSystems today announced the launch of the new Maestro Volttm, an affordable benchtop microelectrode array (MEA) system designed to meet the demands of academic labs with lower throughput needs and limited budgets. Featuring the same ease of...

Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further develop Enlaza's proprietary covalent protein technologies and to support advancement of...

PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company (President and CEO: Patrick C. Reid, hereinafter "PeptiDream") (Tokyo: 4587) today announced an expansion of its peptide discovery collaboration with Swiss-based Novartis...

Enanta Pharmaceuticals, Inc. , a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today announced the appointment of Matthew P. Kowalsky, J.D., as Chief Legal Officer. In this...

Mission Bio, a leader in single-cell multi-omics solutions for precision medicine, announced a new publication led by Hervé Avet-Loiseau, MD, PhD, revealing new insights into disease progression of multiple myeloma (MM). Using Mission Bio's...

ProMIS Neurosciences Inc. , a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis...

FY-2023 Revenues increased by 22% at $10.0 million compared to $8.2 million for FY-2022, a $1.8 million increase.Gross margins for FY-2023 up $3.8 million compared to FY-2022Net loss for FY-2023 of $8.5 million compared to $8.1 million for...

Bio-Techne Corporation today announced the appointment of Dr. Judith Klimovsky to serve as an independent director on the Company's Board of Directors, April 24, 2024. Dr. Klimovsky will serve as a member of the Science and Technology Committee....

Delivered solid performance to start 2024, with record-breaking first quarter revenue of 34.1 billion KRW. Strong sales momentum continued from key products, funding investments in ongoing R&D programs.Phase 3 VELOS-4 study of tanfanercept in dry eye...

Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies...

NexCore Group, a leading healthcare real estate development, investment, and management company, has partnered with one of the nation's leading providers of healthcare service, HCA Healthcare, to celebrate the groundbreaking of a new ambulatory...

Kain Capital LLC, a leading private equity firm focused on the technology enablement of healthcare services companies, today announced that it has made an investment in Essen Health Care ("Essen" or "the Company"), the largest independent healthcare...

Oncolytics Biotech® Inc. , a leading clinical-stage company specializing in immunotherapy for oncology, today announced that it will host a conference call and webcast on Thursday, May 9, 2024, at 4:30 p.m. ET to discuss a corporate update and...

ONO Pharmaceutical, Co., Ltd., (TSE: 4528, Representative Director, Chairman of the Board and Chief Executive Officer: Gyo Sagara, "ONO") and Deciphera Pharmaceuticals, Inc. today announced that on April 29, 2024 (Japan time), ONO and Deciphera...

DURECT Corporation , a late-stage biopharmaceutical company pioneering the development of epigenetic therapies to transform the treatment of serious and life-threatening conditions such as acute organ injury and cancer, today announced acceptance of...

WindRose Health Investors, LLC ("WindRose"), the New York-based healthcare private equity firm, announced that it has completed the acquisition of SubjectWell, the patient access marketplace that connects people with health conditions to care...

I-Mab (the "Company") , a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced that it has filed its annual...

ELIAS Animal Health, a leading companion animal cancer therapeutics company, is expanding its manufacturing capacity in a larger facility located in Lenexa, Kansas as it prepares for the commercial product launch of the ELIAS Cancer Immunotherapy...

Harmony Biosciences , today announced the acquisition of Epygenix Therapeutics, Inc., accelerating its growth...

MD Logic Health® raises the bar in gut health innovation with its new Low Molecular Bioactive Colostrum, offering unmatched potency and efficacy. This supplement, sourced from hormone-free, grass-fed cattle on a nutrient-rich diet, exceeds...

EDCare, a leading provider of eating disorder treatment services, announced the expansion of its treatment options in Colorado, Kansas, and Nebraska to include a Virtual Intensive Outpatient Program (IOP). The virtual program offers flexible support...

Delta Development Team, Inc. is thrilled to announce two significant milestones with the AABB (Association for the Advancement of Blood & Biotherapies). Our medical devices, the Autonomous Portable Refrigeration Unit (APRU6L) and the Delta ICE2L...

The collaboration aims to improve North American healthcare by integrating Microsoft Azure and its AI with WELL's digital health platform to improve clinical outcomes, optimize costs, and ensure top-tier data privacy and security.The integration is...

The fourth survey of the financial anxiety index carried out by Centraide of Greater Montreal in collaboration with Leger has revealed that half of Quebeckers (48%) are feeling significant (moderate to extreme) levels of financial stress. This is a...

DolCas Biotech, LLC will introduce a new prototype of delicious chocolate laced with its flagship curcumin ingredient Curcugen® to demonstrate its versatility in functional foods and beverages. The tasty reveal will occur at the Vitafoods Europe in...

Emmetrope Ophthalmics LLC ("Emmecell"), a clinical-stage biotechnology company pioneering the discovery and development of cell-based therapies for the treatment of serious eye diseases, today announced final dose administration for the...

The Prebys Foundation has launched a $7 million program designed to bring more diverse perspectives into the laboratory and yield ground-breaking medical research. The initiative seeks to address the critical gap in women and underrepresented groups...

Future Market Insights (FMI) predicts a robust future for the scaffold technology market. This growth is primarily driven by advancements in tissue engineering and regenerative medicine. As these fields develop, demand for innovative scaffold...

Revenue in Q1 2024 increased 26%, driven by Mounjaro, Zepbound, Verzenio and Jardiance. Pipeline progress included positive results from two Phase 3 trials of tirzepatide for obstructive sleep apnea; submission of mirikizumab for Crohn's disease in...

Associated Medical Professionals of NY (A.M.P.) is pleased to announce that internationally recognized radiation oncology physician, researcher and thought leader Steven E. Finkelstein, M.D., DABR, FACRO, has joined its care team as Director of the...